These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9484872

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of age and gender on the pharmacokinetics of grepafloxacin.
    Efthymiopoulos C, Bramer SL, Maroli A.
    Clin Pharmacokinet; 1997; 33 Suppl 1():9-17. PubMed ID: 9433651
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Grepafloxacin pharmacokinetics in individuals with hepatic dysfunction.
    Efthymiopoulos C, Bramer SL, Maroli A, Flaherty JF, Wolfe E, Bass N, Somberg K.
    Clin Pharmacokinet; 1997; 33 Suppl 1():25-31. PubMed ID: 9433653
    [Abstract] [Full Text] [Related]

  • 7. Effect of renal impairment on the pharmacokinetics of grepafloxacin.
    Efthymiopoulos C, Bramer SL, Maroli A, Gambertoglio JG.
    Clin Pharmacokinet; 1997; 33 Suppl 1():32-8. PubMed ID: 9433654
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y, Momota K, Morino A.
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Grepafloxacin--a new fluoroquinolone.
    Med Lett Drugs Ther; 1998 Jan 30; 40(1019):17-8. PubMed ID: 9465856
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and ocular penetration of grepafloxacin in albino and pigmented rabbits.
    Perez S, Solans C, Bregante MA, Pinilla I, García MA, Honrubia F.
    J Antimicrob Chemother; 2002 Oct 30; 50(4):541-5. PubMed ID: 12356799
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and safety of NM441, a new quinolone, in healthy male volunteers.
    Nakashima M, Uematsu T, Kosuge K, Okuyama Y, Morino A, Ozaki M, Takebe Y.
    J Clin Pharmacol; 1994 Sep 30; 34(9):930-7. PubMed ID: 7983237
    [Abstract] [Full Text] [Related]

  • 18. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
    Meyerhoff C, Dilger C, Yoon SJ, Chung YH, Lee DK, Lee CW, Ryu JM, Choi MS, Pabst G, Reh C.
    J Antimicrob Chemother; 1998 Sep 30; 42(3):349-61. PubMed ID: 9786475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Grepafloxacin.
    Wagstaff AJ, Balfour JA.
    Drugs; 1997 May 30; 53(5):817-24; discussion 825-7. PubMed ID: 9129868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.